Early Case Management on Recovery From a Cardiac Event in Women

Status Active, not recruiting

Clinical Trial Summary

Outpatient cardiac rehabilitation (CR) is an exercise-based lifestyle program for patients who have experienced a myocardial infarction, systolic heart failure, percutaneous revascularization or cardiac surgery. CR plays a key role in secondary prevention, which is the prevention of subsequent cardiac events. CR has been shown to reduce both cardiovascular mortality and one year hospital readmissions as well as improve quality of life, exercise capacity, and physical function. Although the benefits have been clearly established for cardiac patients, women are much less likely to attend CR than men. Based upon our own preliminary data (and the medical literature), attendance at CR is determined by factors that vary in their importance between men and women. These findings demonstrate that older age and poor social support are particular barriers to CR participation in women. This information can guide efforts to increase CR participation and adherence in women, areas which have received little study. Case management (CM) has been effective at reducing cardiovascular risk and reducing hospitalizations amongst cardiac patients. Further, CM has been effective at promoting attendance in a variety of health related programs (for example, diabetes treatment or cocaine dependence treatment). The primary aim in this randomized controlled trial is to examine the efficacy of early CM to promote participation and adherence in CR. The CM model can identify individualized determinants of health and social needs to identify potential barriers which may hinder CR enrollment. Additionally, the case manager will conduct a home visit and provide individual counseling to address lifestyle changes including physical activity. Thus, a component of CR and physical activity can be still be delivered for those unable to attend CR. The concept of CM to improve CR participation and adherence has not been specifically tested in women, a vulnerable patient population. This intervention, therefore, has the potential to increase utilization of CR and significantly improve health outcomes in female cardiac patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04693988
Study type	Interventional
Source	University of Vermont Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 18, 2021
Completion date	December 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05956912` - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting	`NCT05773287` - Targeted Health Coaching to Improve Physical Activity Post-Structured Cardiac Rehabilitation	N/A
Completed	`NCT05551429` - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Completed	`NCT02542163` - Pilot Evaluation of the NimbleHeart Harness System in Cardiac Rehabilitation (PEN-CR)	N/A
Not yet recruiting	`NCT05989594` - Home-based Mobile Guided Exercise-based Cardiac Rehabilitation Among Patients Undergoing TAVR	N/A
Active, not recruiting	`NCT05026957` - A Digitally-Supported Shared Decision Making Approach for Coronary Artery Disease Patients During Cardiac Rehabilitation	N/A
Recruiting	`NCT03734185` - Cardiac Rehabilitation: From Hospital to Municipal Setting.	N/A
Recruiting	`NCT05826587` - Cardiac Rehabilitation Mobile-Health Fall Risk Prevention Intervention	N/A
Completed	`NCT03174106` - Longterm Follow-up of Cardiac Patients With an Smartphone-Application	N/A
Recruiting	`NCT05725655` - Hot Water Immersion After Myocardial Infarction	N/A
Not yet recruiting	`NCT05019157` - Cardiac Telerehabilitation Effectiveness Using Wearable Sensors	N/A
Recruiting	`NCT06025526` - Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot)	N/A
Recruiting	`NCT05099692` - CHD Patient's Concern on Cardiac Rehabilitation
Completed	`NCT06306235` - Are Non-participants of Conventional Centre-based Cardiac Rehabilitation Willing to Participate in Cardiac Telerehabilitation?
Recruiting	`NCT06039969` - Evaluate Aerobic Exercise on Myocardial Fibrosis and Intestinal Flora in Dilated Cardiomyopathy Diagnosed First Time.
Not yet recruiting	`NCT06065319` - Wearables and Cardiac Rehabilitation
Recruiting	`NCT06127537` - Study on the Efficacy of HE and Therapeutic Group Factors on CR and QoL	N/A
Completed	`NCT04738383` - Feasibility and Acceptance of Changes in Medical Supervision of Exercise Groups in Cardiac Rehabilitation	N/A
Active, not recruiting	`NCT03922529` - Modified Application of Cardiac Rehabilitation for Older Adults	N/A
Completed	`NCT00956657` - Improving Cardiac Rehabilitation Session Attendance: A Randomised Controlled Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.